Members of the SRC family kinases have been broadly investigated in cancer due to their pro-oncogenic characteristics,[53,54] and results for SRC targeting have also been reported in the treatment of hepatic fibrosis.[55,56]. The gene discussed is SRC; the disease is Hepatic fibrosis.